We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Varman Samuel MD, PhD

Varman T. Samuel MD, PhD

Associate Professor of Medicine, Section of Endocrinology, Yale School of Medicine, New Haven, Connecticut; Section Chief, Endocrinology, VA Connecticut Healthcare System

Dr. Varman T. Samuel is an adult endocrinologist with a particular interest in the exploring the mechanisms by which the development of nonalcoholic fatty liver disease impacts hepatic insulin action and hepatic carbohydrate metabolism. His research interests include the role of the sn 1,2-diacyglycerol-PKCε pathway for insulin resistance, the role of pyruvate carboxylase in regulating hepatic gluconeogenesis, the impact of dietary fructose on the development of insulin resistance and recently, the intersection between alcoholic- and non-alcoholic fatty liver disease. He is currently an Associate Professor of Medicine at Yale University School of Medicine and chief of Endocrinology for VA Connecticut Healthcare System.


Dr. Samuel has no relevant disclosures.